Genetic basis for personalized medicine in asthma
- 1 April 2012
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Respiratory Medicine
- Vol. 6 (2) , 223-236
Abstract
There is heterogeneity in patient responses to current asthma medications. Significant progress has been made identifying genetic polymorphisms that influence the efficacy and potential for adverse effects to asthma drugs, including; β(2)-adrenergic receptor agonists, corticosteroids and leukotriene modifiers. Pharmacogenetics holds great promise to maximise clinical outcomes and minimize adverse effects. Asthma is heterogeneous with respect to clinical presentation and inflammatory mechanisms underlying the disease, which is likely to contribute to variable results in clinical trials targeting specific inflammatory mediators. Genome-wide association studies have begun to identify genes underlying asthma (e.g., IL1RL1), which represent future therapeutic targets. In this article, we review and update the pharmacogenetics of current asthma therapies and discuss the genetics underlying selected Phase II and future targets.Keywords
This publication has 83 references indexed in Scilit:
- Gene–environment interactions in human disease: nuisance or opportunity?Trends in Genetics, 2011
- Association between ORMDL3, IL1RL1 and a deletion on chromosome 17q21 with asthma risk in AustraliaEuropean Journal of Human Genetics, 2010
- A Large-Scale, Consortium-Based Genomewide Association Study of AsthmaNew England Journal of Medicine, 2010
- Using genetics to predict the natural history of asthma?Journal of Allergy and Clinical Immunology, 2010
- Variants ofDENND1BAssociated with Asthma in ChildrenNew England Journal of Medicine, 2010
- Genome-wide Association Analysis Identifies PDE4D as an Asthma-Susceptibility GeneThe American Journal of Human Genetics, 2009
- Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarctionNature Genetics, 2009
- Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthmaNature, 2007
- Pharmacogenetics and asthma: false hope or new dawn?: Table 1—European Respiratory Journal, 2007
- Proceedings of the ATS Workshop on Refractory AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2000